ConvaTec Group PLC (CTEC) - Net Assets

Latest as of June 2025: GBX1.81 Billion GBX ≈ $220.37K USD

Based on the latest financial reports, ConvaTec Group PLC (CTEC) has net assets worth GBX1.81 Billion GBX (≈ $220.37K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX3.77 Billion ≈ $458.88K USD) and total liabilities (GBX1.96 Billion ≈ $238.51K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ConvaTec Group PLC liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX1.81 Billion
% of Total Assets 48.02%
Annual Growth Rate N/A
5-Year Change 1.09%
10-Year Change N/A
Growth Volatility 7.99

ConvaTec Group PLC - Net Assets Trend (2009–2024)

This chart illustrates how ConvaTec Group PLC's net assets have evolved over time, based on quarterly financial data. Also explore ConvaTec Group PLC assets under control for the complete picture of this company's asset base.

Annual Net Assets for ConvaTec Group PLC (2009–2024)

The table below shows the annual net assets of ConvaTec Group PLC from 2009 to 2024. For live valuation and market cap data, see ConvaTec Group PLC market capitalisation.

Year Net Assets Change
2024-12-31 GBX1.69 Billion
≈ $205.49K		 -0.22%
2023-12-31 GBX1.69 Billion
≈ $205.95K		 +5.16%
2022-12-31 GBX1.61 Billion
≈ $195.85K		 -5.02%
2021-12-31 GBX1.69 Billion
≈ $206.21K		 +1.44%
2020-12-31 GBX1.67 Billion
≈ $203.28K		 +7.03%
2019-12-31 GBX1.56 Billion
≈ $189.93K		 -3.48%
2018-12-31 GBX1.62 Billion
≈ $196.77K		 +6.13%
2017-12-31 GBX1.52 Billion
≈ $185.40K		 +22.28%
2016-12-31 GBX1.25 Billion
≈ $151.63K		 +669.56%
2015-12-31 GBX-218.80 Million
≈ $-26.62K		 +89.94%
2014-12-31 GBX-2.17 Billion
≈ $-264.59K		 -1.97%
2013-12-31 GBX-2.13 Billion
≈ $-259.46K		 -14.85%
2012-12-31 GBX-1.86 Billion
≈ $-225.91K		 -11.43%
2011-12-31 GBX-1.67 Billion
≈ $-202.74K		 -17.35%
2010-12-31 GBX-1.42 Billion
≈ $-172.77K		 -49.54%
2009-12-31 GBX-949.60 Million
≈ $-115.54K		 --

Equity Component Analysis

This analysis shows how different components contribute to ConvaTec Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 153900000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX251.50 Million 14.89%
Other Components GBX2.27 Billion 134.16%
Total Equity GBX1.69 Billion 100.00%

ConvaTec Group PLC Competitors by Market Cap

The table below lists competitors of ConvaTec Group PLC ranked by their market capitalization.

Company Market Cap
InkTec Co. Ltd
KQ:049550
 $49.83 Million
Tadmax Resources Berhad
KLSE:4022
 $49.83 Million
Indopoly Swakarsa Industry Tbk
JK:IPOL
 $49.84 Million
Seowon
KO:021050
 $49.87 Million
LOOP INDUSTRIES DL-001
F:3L9
 $49.79 Million
Aton Resources Inc
V:AAN
 $49.79 Million
Opticis Company Limited
KQ:109080
 $49.78 Million
Nanoform Finland Plc
HE:NANOFH
 $49.78 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ConvaTec Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,692,700,000 to 1,688,900,000, a change of -3,800,000 (-0.2%).
  • Net income of 190,500,000 contributed positively to equity growth.
  • Dividend payments of 130,200,000 reduced retained earnings.
  • Share repurchases of 10,900,000 reduced equity.
  • Other comprehensive income decreased equity by 2,149,500,000.
  • Other factors increased equity by 2,096,300,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX190.50 Million +11.28%
Dividends Paid GBX130.20 Million -7.71%
Share Repurchases GBX10.90 Million -0.65%
Other Comprehensive Income GBX-2.15 Billion -127.27%
Other Changes GBX2.10 Billion +124.12%
Total Change GBX- -0.22%

Book Value vs Market Value Analysis

This analysis compares ConvaTec Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 255.74x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 GBX-1.09 GBX210.00 x
2014-12-31 GBX-1.11 GBX210.00 x
2015-12-31 GBX-0.11 GBX210.00 x
2016-12-31 GBX0.64 GBX210.00 x
2017-12-31 GBX0.78 GBX210.00 x
2018-12-31 GBX0.83 GBX210.00 x
2019-12-31 GBX0.79 GBX210.00 x
2020-12-31 GBX0.83 GBX210.00 x
2021-12-31 GBX0.84 GBX210.00 x
2022-12-31 GBX0.79 GBX210.00 x
2023-12-31 GBX0.82 GBX210.00 x
2024-12-31 GBX0.82 GBX210.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently ConvaTec Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 11.28%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.32%
  • • Asset Turnover: 0.65x
  • • Equity Multiplier: 2.08x
  • Recent ROE (11.28%) is above the historical average (3.75%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 0.00% -10.21% 0.37x 0.00x GBX39.55 Million
2014 0.00% -16.52% 0.44x 0.00x GBX-69.04 Million
2015 0.00% -5.66% 0.44x 0.00x GBX-71.52 Million
2016 -16.27% -12.01% 0.48x 2.82x GBX-327.42 Million
2017 10.40% 8.98% 0.46x 2.49x GBX6.02 Million
2018 13.70% 12.10% 0.50x 2.26x GBX59.88 Million
2019 0.63% 0.54% 0.51x 2.31x GBX-146.30 Million
2020 6.73% 5.94% 0.50x 2.25x GBX-54.57 Million
2021 6.94% 5.77% 0.55x 2.17x GBX-51.88 Million
2022 3.91% 3.03% 0.58x 2.23x GBX-98.07 Million
2023 7.70% 6.08% 0.58x 2.19x GBX-38.97 Million
2024 11.28% 8.32% 0.65x 2.08x GBX21.61 Million

Industry Comparison

This section compares ConvaTec Group PLC's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $52,431,484
  • Average return on equity (ROE) among peers: 21.99%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
ConvaTec Group PLC (CTEC) GBX1.81 Billion 0.00% 1.08x $49.81 Million
Advanced Medical Solutions Group plc (AMS) $152.44 Million 13.21% 0.11x $6.32 Million
Inspecs Group plc (SPEC) $2.23 Million 31.80% 5.43x $1.03 Million
Tristel (TSTL) $2.63 Million 20.95% 0.78x $2.36 Million

About ConvaTec Group PLC

LSE:CTEC UK Medical Instruments & Supplies
Market Cap
$49.81 Million
GBX409.38 Billion GBX
Market Cap Rank
#21897 Global
#153 in UK
Share Price
GBX210.00
Change (1 day)
-0.38%
52-Week Range
GBX210.00 - GBX295.40
All Time High
GBX295.40
Categories
Companies in UK Medical Instruments & Supplies
About

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more